Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
5
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
biotech
fda
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boston
eli lilly
indiana blog main
indiana top stories
parkinson's disease
rna interference
wisconsin blog main
wisconsin top stories
abbvie
acorda therapeutics
akcea therapeutics
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceutials
alnylam pharmaceuticals
amgen
ampyra
andrew fire
apokyn
apomorphine
arrowhead pharmaceuticals
bial
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
What
gets
5
×
fda
drug
nod
approved
disease
medicines
new
parkinson’s
patients
rnai
abandoning
acorda
add
afternoon
ago
alnylam
alnylam’s
amgen
approval
baggage
called
candidates
carbidopa
class
combination
companies
control
cope
cuts
daily
deal
developed
development
dicerna
episodes
experience
free
friday
head
Language
unset
Current search:
gets
×
" clinical trials "
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines